Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this trial is to evaluate the safety and tolerability of extended treatment with depsipeptide in patients who have at least demonstrated stable disease on a prior Gloucester-sponsored depsipeptide clinical trial, and in the opinion of their physician/investigator might benefit from continued treatment with depsipeptide.
Critère d'inclusion
- Refractory Prostate cancer